Synonyms: 3,4-DAP | 3,4-diaminopyridine | Firdapse® | Ruzurgi® | Zenas®
amifampridine is an approved drug (EMA (2009), FDA (2018))
Compound class:
Synthetic organic
Comment: Amifampridine is a potassium channel blocker.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (EMA (2009), FDA (2018)) |
Approved drug? | Yes. EMA (2009) | FDA (2018) |
IUPAC Name ![]() |
pyridine-3,4-diamine |
International Nonproprietary Names ![]() |
|
INN number | INN |
8804 | amifampridine |
Synonyms ![]() |
3,4-DAP | 3,4-diaminopyridine | Firdapse® | Ruzurgi® | Zenas® |
Database Links ![]() |
|
CAS Registry No. | 54-96-6 |
ChEMBL Ligand | CHEMBL354077 |
DrugCentral Ligand | 4336 |
GtoPdb PubChem SID | 249565712 |
PubChem CID | 5918 |
RCSB PDB Ligand | L89 |
Search Google for chemical match using the InChIKey | OYTKINVCDFNREN-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | OYTKINVCDFNREN |
Search PubMed clinical trials | amifampridine |
Search PubMed titles | amifampridine |
Search PubMed titles/abstracts | amifampridine |
UniChem Compound Search for chemical match using the InChIKey | OYTKINVCDFNREN-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | OYTKINVCDFNREN-UHFFFAOYSA-N |
Wikipedia | 3,4-Diaminopyridine |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Amifampridine (links to external site)
Cat. No. HY-14946 |